At a glance

ClinicalIndex Comparison Record

Phase 4Unknown· 520 target

Drug / intervention

Yangzhengxiaoji Capsule +1 moredrug

Likely dose

Yangzhengxiaoji Capsule 1000mgfrom record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02195453

NCT02195453Phase 4Unknown

Compare CT.gov

A Randomized,Double-blind,Placebo-Controlled,Multicenter Clinical Trail of Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer

Shandong Cancer Hospital and Institute·interventional·Posted Jul 21, 2014·Updated Jul 21, 2014

In Brief

A Phase 4 clinical trial evaluating Yangzhengxiaoji Capsule and Placebo Capsule for Non-Small Cell Lung Cancer. Targeting 520 participants.

Detailed Summary

The purpose of this study is to observe quality of life and treatment side effects in patients with advanced non small cell lung cancer (NSCLC) receive chemotherapy and Yangzhengxiaoji capsule.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsNon-Small Cell Lung Cancer

Countries--

CollaboratorsPeking University Cancer Hospital & Institute

Timeline

Phase 4UnknownOverdue

201520162017201820192020202120222023202420252026

First PostedJul 2014

Enrollment StartAug 2014

Primary CompletionSep 2016

Study CompletionDec 2016

TodayJul 2026

First PostedJul 21, 2014

Enrollment StartAug 1, 2014

Primary CompletionSep 1, 2016

Study CompletionDec 1, 2016

TodayJul 1, 2026

Enrollment to primary: 2.1 yearsPosted 11.9 years ago

Interventions

Yangzhengxiaoji Capsuledrug

Gemcitabine 1000mg/m² or Pemetrexed 500mg/m² IV drip on D1 and D8,21 days for a cycle. Cisplatin 75mg/m² IV drip for one day or two-three days total injection,21 days for a cycle. Yangzhengxiaoji Capsule four granules t.i.d po.

Placebo Capsuledrug

Gemcitabine 1000mg/m² or Pemetrexed 500mg/m²IV drip on D1 and D8,21 days for a cycle. Cisplatin 75mg/m² IV drip for one day or two-three days total injection, 21 days for a cycle. Placebo Capsule four granules t.i.d po.